Selective decrease in colonic CD56+ T and CD161+ T cells in the inflamed mucosa of patients with ulcerative colitis

doi:10.3748/wjg.v13.i45.5995

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2621)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

793

HTML

1396

Figures (1-6)

184

Tables (1-1)

248

Sum=2621

Dec 7, 2007 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 7, 2007; 13(45): 5995-6002
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.5995

Full Size Figure Download Figure

Figure 5 The percentage of colonic NKR⁺ T cells was not affected by treatment with PSL or AZA. The percentages of colonic NKR⁺ T cells were compared between untreated UC patients and those treated with PSL (A, B). The level of NKR⁺ T cells was compared between untreated UC patients and those treated with AZA (C, D). “n“ indicates the number of cases.

Citation: Shimamoto M, Ueno Y, Tanaka S, Onitake T, Hanaoka R, Yoshioka K, Hatakeyama T, Chayama K. Selective decrease in colonic CD56⁺ T and CD161⁺ T cells in the inflamed mucosa of patients with ulcerative colitis. World J Gastroenterol 2007; 13(45): 5995-6002
URL: https://www.wjgnet.com/1007-9327/full/v13/i45/5995.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i45.5995